The global bacteriophage market is expected to grow at compound annual growth rate (CAGR) of 4.5%. Raise in incidence of antimicrobial resistance will lead to growth in Bacteriophage market in the upcoming years. According to Centers for disease control & prevention CDC at least 23,000 of people in the United States & around 33,000 people in Europe die due to antibiotic resistant infections. With increasing inpatient care there has been a rise in the adoption of bacteriophage in phage research centers, along with bacteriophage supplements. Bacteriophage is also known as phage therapy and it needs viruses for the medication of bacterial infections. Bacterial viruses are called phages or bacteriophages. Bacteriophages are supposed to be natural antagonists of bacteria and are found in soil, water, sewage & other places where bacterias are exposed. With the recent advances in technology, particularly the ability to elucidate genome sequences of bacterial hosts, there has been a renewed interest in phages. Traditionally, phages have been considered as a nuisance in the industrial processes that depend on bacterial fermentation. Since the discovery of bacteriophages, many researchers have considered their potential as therapeutic agents. After the World War II, when antibiotics were discovered, the natural potential of bacteriophages received little attention and was considered only as a research tool. Bacteriophages have significantly contributed in the field of biotechnology and molecular biology and are still playing an important role. Today, their potential to be used as phage display systems, antibacterials, vehicles for vaccines and biocontrol agents, and the attention towards bacteriophages is rekindled.  

Increasing R&D is Expected to Multiply Revenues 

The Bacteriophage market is expected to grow at a significant rate due to rising manufacturing of antibiotic resistant infection, rising research activities for development of therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players. Emergence of e-Commerce is increasing the share of pharmaceuticals companies. Most companies are focusing on setting up online stores of Bacteriophage preparations to make phages and phage therapy available across the world. The Bacteriophage must be treated with safety precautions & there is no data related to these methods. . Increasing government funding to support phage therapy manufacturers in developing an innovative approach to decrease antimicrobial-resistant infection cases is anticipated to boost market growth. 

"Food & Beverages Display Highest Share by Application in Bacteriophage Market" At present food & beverages occupy the largest revenue share in the global bacteriophage market. Bacteriophages find the widest application in food biocontrol and present as a natural and green method that uses lytic bacteriophages derived from the environment to target pathogenic bacteria. Since the initial conception of the use of bacteriophages on foods, additional research are also being conducted for using bacteriophage to target pathogenic bacteria in ready to eat meals, fresh fruits, dairy products and vegetables. This has led to increase in approved products containing bacteriophages for food safety applications. Clinical applications of bacteriophages will witness the fastest market growth during the forecast period. Increased use of bacteriophages in diagnostics, phage display technology and potential use in drug discovery and development are the main attributes to the fast growth of this segment. 

North America Remains the Market Leader 

Growing failure of antibiotic treatment to fight against infections such as multi-drug resistant Staphylococcus aureus has renewed interest in bacteriophage therapy in countries such as Georgia Poland Russia etc. The U.S. bacteriophage market is expanding due to rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country. However, lack of regulatory approval by USFDA for therapeutic bacteriophages is somewhat hampering market expansion in the U.S. 

North America held the largest regional market share for bacteriophage market in 2020. Strong desire to overcome the burden of antibiotic-resistant infections, strongly established research infrastructure, and existence of potential pipeline for phage therapy are the key attributes of North America market. Europe is the second largest market for bacteriophage on the grounds of wide application of bacteriophage in food and environmental fields and stable presence of phage therapy in the region. Asia Pacific will witness the fastest progress in the global market. Rapidly evolving biotechnology infrastructure, evolving agriculture practices, and equally supportive government initiatives contribute to the rapid growth of Asia Pacific market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Bacteriophage market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Bacteriophage market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Bacteriophage market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Bacteriophage market?
• Which is the largest regional market for Bacteriophage market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Bacteriophage market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Bacteriophage market worldwide?